New Comprehensive Cancer Center Launches in Amarillo
By HCO Staff
AMARILLO, Texas—Texas Oncology has opened a new 50,000-square-foot cancer center in Amarillo, significantly expanding the capacity of the practice to meet the growing need for cancer care in the Texas Panhandle region. Located at 1826 Point West Pkwy., the new comprehensive cancer center provides medical oncology, hematology, gynecologic oncology, radiation oncology, breast imaging, surgical oncology, and colon and rectal surgery.
“As the population of the Texas Panhandle region continues to grow, this new facility will help ensure that cancer patients in Amarillo have access to high-quality care,” said Steven Paulson, M.D., president and chief executive officer. “By providing innovative and individualized care to patients in Amarillo and its surrounding communities, Texas Oncology reinforces its commitment to being the first choice for cancer care across Texas.”
In addition to multi-disciplinary cancer care, the new center provides a full-service medically integrated pharmacy, access to clinical trials, genetic testing and evaluation, educational services, and support groups to address patients’ psychological and emotional health. The center also provides 2D and 3D screening and diagnostic mammography through Texas Breast Specialists–Amarillo, which is designated by the American College of Radiology as a Breast Imaging Center of Excellence.
“Texas Oncology has deep roots in the Amarillo community, and we’re proud to have served this region for nearly two decades,” said Praveen Tumula, M.D., medical oncologist and area medical director, Texas Oncology–Amarillo Cancer Center. “We want patients and their loved ones to walk into this new facility and feel confident they have the comprehensive care and support they need through every stage of their cancer journey.”
Texas Oncology’s Amarillo staff includes 10 physicians and more than 100 additional clinical and support team members – connected to a medical practice comprising of more than 530 physicians and nearly 6,000 employees across the state. The new Amarillo facility is part of a more than $150 million investment by Texas Oncology in capital improvements statewide over the past six years. The practice continues to grow with expanded colon and rectal, breast, and other surgical specialties, as well as offering more patients access to clinical trials while remaining committed to diagnostic and treatment innovations such as immunotherapy, biomarker testing, precision medicine, proton therapy, radiation therapy, and radiopharmaceuticals.